Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TROGLITAZONE
- Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
- Incretin-based Drugs and Acute Pancreatitis
- Incretin-based Drugs and Pancreatic Cancer
- Incretin-based Drugs and the Risk of Heart Failure
- A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent Diabetes
- Regression of Myocardial Steatosis by Nebivolol
- To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies
- Fracture Risk With Thiazolidinediones
- Glibenclamide (Dose to be Titrated From Starting Dose of 5mg om) Plus Rosiglitazone 4mg om (Increased to 8mg om After 6 Months) and vs Glibenclamide (Dose to be Titrated With Starting Dose of 5mg om) Plus Placebo, Administered to Patients With Type
- Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)
- To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients
- Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCI
- Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic Patients
- Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability
- TART - Troglitazone Atherosclerosis Regression Trial
- Troglitazone in Treating Patients With Liposarcoma
Clinical trials list
click for details